Therefore, an investigation of the IR-associated activation of the cGAS/STING/IFN-1 cascade in non-cancer cells in the tumor microenvironment is also of great interest to support the immunogenic impact of RT in STING-negative or -inactive tumors. The gene discussed is STING1; the disease is neoplasm.